158 related articles for article (PubMed ID: 37971139)
1. The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology.
Sengul I; Sengul D
Rev Assoc Med Bras (1992); 2023; 69(12):e20231124. PubMed ID: 37971139
[No Abstract] [Full Text] [Related]
2. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
3. Evangely, the subcategorization has been announced in the 2023 Bethesda system for reporting thyroid cytopathology: let bygones be bygones in thyroidology!
Sengul I; Sengul D
Rev Assoc Med Bras (1992); 2024; 70(3):e20231511. PubMed ID: 38656016
[No Abstract] [Full Text] [Related]
4. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.
Rossi M; Lupo S; Rossi R; Franceschetti P; Trasforini G; Bruni S; Tagliati F; Buratto M; Lanza G; Damiani L; Degli Uberti E; Zatelli MC
Endocrine; 2017 Jul; 57(1):98-107. PubMed ID: 27623969
[TBL] [Abstract][Full Text] [Related]
5. A brief description of the Bethesda System for reporting thyroid fine needle aspirates.
Schinstine M
Hawaii Med J; 2010 Jul; 69(7):176-8. PubMed ID: 20680928
[TBL] [Abstract][Full Text] [Related]
6. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category 5 thyroid nodules: Not as risky as we think?
Wright K; Brandler TC; Fisher JC; Rothberger GD; Givi B; Prescott J; Suh I; Patel KN
Surgery; 2023 Jan; 173(1):239-245. PubMed ID: 36511283
[TBL] [Abstract][Full Text] [Related]
8. The national rate of malignancy among Bethesda III, IV, and V thyroid nodules is higher than expected: A NSQIP analysis.
Delman AM; Turner KM; Ammann AM; Sisak S; Farooqui Z; Holm TM
Surgery; 2023 Mar; 173(3):645-652. PubMed ID: 36229250
[TBL] [Abstract][Full Text] [Related]
9. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
Jo VY; Stelow EB; Dustin SM; Hanley KZ
Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
[TBL] [Abstract][Full Text] [Related]
10. Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation.
Mastorakis E; Meristoudis C; Margari N; Pouliakis A; Leventakos K; Chroniaris N; Panayiotides I; Karakitsos P
Cytopathology; 2014 Apr; 25(2):120-8. PubMed ID: 23551656
[TBL] [Abstract][Full Text] [Related]
11. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
Choden S; Wangmo C; Maharjan S
Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
[TBL] [Abstract][Full Text] [Related]
12. Current issues in fine needle aspiration biopsy of thyroid gland.
Dušková J
Cesk Patol; 2019; 55(1):13-23. PubMed ID: 30939883
[TBL] [Abstract][Full Text] [Related]
13. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
[TBL] [Abstract][Full Text] [Related]
14. The Bethesda system for reporting thyroid fine needle aspirates: A study of 1763 patients; with histopathological correlations, in eastern India.
Sen A; Sarkar M; Das RN; Paul SS; Chatterjee U
Diagn Cytopathol; 2023 Mar; 51(3):174-181. PubMed ID: 36409469
[TBL] [Abstract][Full Text] [Related]
15. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
Arnold MA; Nicol KK
Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
[TBL] [Abstract][Full Text] [Related]
16. The Bethesda System for Reporting Thyroid Cytopathology II.
Ali SZ; Cibas ES
Acta Cytol; 2016; 60(5):397-398. PubMed ID: 27788511
[No Abstract] [Full Text] [Related]
17. [Up-to-date experience with the international classification system Bethesda 2010 for thyroid fine-needle aspirate: a review].
Ludvíková M; Kholová I
Cesk Patol; 2014 Jul; 50(3):155-60. PubMed ID: 25186598
[TBL] [Abstract][Full Text] [Related]
18. Fine needle aspiration and the Bethesda system: Correlation with histopathology in 1,228 surgical patients.
Linhares SM; Handelsman R; Picado O; Farrá JC; Lew JI
Surgery; 2021 Nov; 170(5):1364-1368. PubMed ID: 34134896
[TBL] [Abstract][Full Text] [Related]
19. The Bethesda System for Reporting Thyroid Cytopathology.
Cibas ES; Ali SZ
Thyroid; 2009 Nov; 19(11):1159-65. PubMed ID: 19888858
[TBL] [Abstract][Full Text] [Related]
20. [The new system for reporting fine needle aspiration biopsies of the thyroid gland: Bethesda 2010].
Dusková J
Cesk Patol; 2011 Jan; 47(1):8-14. PubMed ID: 21416701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
